Health front page macrophage2


Nano-Safety Research Group

Specialists in the assessment of nanomaterial toxicity to human health and the environment

Funding Sources

The research we conduct has been funded by a variety of funding bodies. Sources of all funding, past and present, include:

European Funding

  • Framework Prgramme 6 (FP6)
  • Framework Prgramme 7 (FP7)
  • Horizon 2020

UK Research Councils 

  • Natural Environment Research Council (NERC)
  • Medical Research Council (MRC)
  • Engineering and Physical Sciences Research Counsil (EPSRC)
  • Biotechnology and Biological Sciences Research Council (BBSRC)
  • NC3Rs: UK National Centre for the Replacement, Refinement and Reduction of animals in research


  • The Colt Foundation
  • The Cunningham Trust
  • PETA


  • Unilever
  • GlaxoSmithKlein (GSK)
  • Solvay
  • Lloyds of London
  • BP
  • National Power
  • Institute of Occupational Medicine
  • BYK


  • UK Department for Environment, Food and Rural Affairs (Defra)
  • UK Department of Health

Meeting/Conference attendance

Travel,and subsistence funding has been provided to various members of the group to attend conferences and meetings from a variety of sources, including:

  • The Aerosol Society 
  • The 12th European Symposium on Controlled Drug Delivery
  • Delft University of Technology
  • The Federal Institute for Risk Assessment, Germany
  • The 2012 Annual UK Review Meeting on Outdoor and Indoor Air Pollution Research Conference
  • The European Environment Agency
  • The Medicines and Healthcare products Regulatory Agency
  • Academy of Pharmaceutical Sciences, Pharm Sci conference
  • 7th World Congress on Alternatives and Animal Use in Life Sciences, Rome